Article Text

Download PDFPDF
Propofol for palliative sedation in catastrophic bleeding
  1. Shalini Ponnampalam and
  2. Heidi Gregory
  1. Palliative Care, Austin Health, Heidelberg, Victoria, Australia
  1. Correspondence to Dr Shalini Ponnampalam, Palliative Care, Austin Health, Heidelberg, Victoria, Australia; shalini.ponnampalam{at}gmail.com

Abstract

Catastrophic bleeds are life-threatening events. This case report describes the successful use of intravenous propofol infusion in order to facilitate palliative sedation in the context of a catastrophic bleed where traditional medications did not yield the necessary level of effect as the patient survived another 72 hours after the onset of the bleeding event. Given the prolonged period post onset of this patient’s catastrophic bleed, this case demonstrates the effective use of an intravenous propofol infusion to facilitate comfort and sedation when drug classes such as benzodiazepines and barbiturates failed to do so. Given the successful outcome detailed in this case, we strongly advocate for the development of guidelines that incorporate propofol alongside other pharmacological measures when addressing palliative sedation.

  • Terminal care
  • Quality of life
  • Pharmacology
  • Palliative Care
  • Hospice care

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors SP completed the write-up of the case report and discussion. The manuscript was reviewed by all authors (SP and HG).

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer-reviewed.